• 1
    Hunter M, Rendall M. Bio-psycho-socio-cultural perspectives on menopause. Best Pract. Res. Clin. Obstet. Gynaecol. 2007; 21: 261274.
  • 2
    Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994; 51: 819.
  • 3
    Chen MY, James K, Liao J. Health issues of aboriginal female adolescents in Taiwan. J. Adv. Nurs. 2004; 47: 401407.
  • 4
    Yang MS, Ko YC, Wen JK. Prevalences and related factors of substances use in female aborigines in southern Taiwan. Kaohsiung J. Med. Sci. 1996; 12: 634640.
  • 5
    Yang MS, Yang MJ. Correlated risk factors for suicidal ideation in aboriginal Southern Taiwanese women of childbearing age. Public Health 2000; 114: 291294.
  • 6
    Ryder AG, Bean G, Dion KL. Caregiver responses to symptoms of first-onset psychosis: A comparative study of Chinese- and Euro-Canadian families. Transcult. Psychiatry 2000; 37: 255265.
  • 7
    Bosworth HB, Bastian LA, Kuchibhatla MN et al. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife. Psychosom. Med. 2001; 63: 603608.
  • 8
    Gyllstrom ME, Schreiner PJ, Harlow BL. Perimenopause and depression: Strength of association, causal mechanisms and treatment recommendations. Best Pract. Res. Clin. Obstet. Gynaecol. 2007; 21: 275292.
  • 9
    Yen CF, Chen CC, Lee Y, Tang TC, Yen JY, Ko CH. Self-stigma and its correlates among outpatients with depressive disorders. Psychiatr. Serv. 2005; 56: 599601.
  • 10
    Trivedi JK, Mishra M, Kendurkar A. Depression among women in the South-Asian region: The underlying issues. J. Affect. Disord. 2007; 102: 219225.
  • 11
    Tsao LI. Relieving discomforts: The help-seeking experiences of Chinese perimenopausal women in Taiwan. J. Adv. Nurs. 2002; 39: 580588.
  • 12
    Ancelin ML, Scali J, Ritchie K. Hormonal therapy and depression: Are we overlooking an important therapeutic alternative? J. Psychosom. Res. 2007; 62: 473485.
  • 13
    Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch. Gen. Psychiatry 2004; 61: 6270.
  • 14
    Greene JG. Constructing a standard climacteric scale. Maturitas 1998; 29: 2531.
  • 15
    Fang MS, Yang MS, Tsai EM. Menopausal symptoms of urban aboriginal women in Taiwan. Formos. J. Med. 2006; 10: 166174.
  • 16
    Chien CP, Cheng TA. Depression in Taiwan: Epidemiological survey utilizing CES-D. Seishin Shinkeigaku Zasshi 1985; 87: 335338.
  • 17
    Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 1977; 1: 385401.
  • 18
    Smilkstein G. The family APGAR: A proposal for a family function test and its use by physicians. J. Fam. Pract. 1978; 6: 12311239.
  • 19
    Chau TT, Hsiao TM, Huang CT, Liu HW. A preliminary study of family Apgar index in the Chinese. Kaohsiung J. Med. Sci. 1991; 7: 2731 (in Chinese).
  • 20
    Harlow BL, Wise LA, Otto MW, Soares CN, Cohen LS. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: The Harvard Study of Moods and Cycles. Arch. Gen. Psychiatry 2003; 60: 2936.
  • 21
    Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: The Harvard study of moods and cycles. Arch. Gen. Psychiatry 2006; 63: 385390.
  • 22
    Amore M, Di DP, Papalini A et al. Psychological status at the menopausal transition: An Italian epidemiological study. Maturitas 2004; 48: 115124.
  • 23
    Van Hook MP. Challenges to identifying and treating women with depression in rural primary care. Soc. Work Health Care 1996; 23: 7392.
  • 24
    Moe KE. Hot flashes and sleep in women. Sleep Med. Rev. 2004; 8: 487497.
  • 25
    Mark A, Shifren J. Medical therapy for female sexual dysfunction. Prim. Care Update Ob Gyns 2003; 10: 4043.
  • 26
    Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J. Sex. Med 2005; 2 (Suppl. 3): 154165.